Our broad-based transaction experience extends across a range of situations, industries and enterprise values
Categories
Year
Type
Industry
Announced: February 26, 2026Value: $110 billionStatus: PendingLead financial advisor to Paramount on its acquisition of Warner Bros. Discovery
Announced: February 3, 2026Value: $12.2 billionStatus: PendingExclusive financial advisor to Santander on its acquisition of Webster Financial Corporation
Announced: February 9, 2026Value: $12 billionStatus: PendingExclusive advisor to FedEx on its partnership with Advent International to make an investment for joint ownership of InPost
Announced: February 17, 2026Value: $9.9 billionStatus: PendingFinancial advisor to Masimo Corporation on its sale to Danaher
Announced: February 23, 2026Value: Up to $8.2 billionStatus: ClosedExclusive financial advisor to Arcellx on its sale to Gilead Sciences
Announced: March 31, 2026Value: Up to $7.8 billionStatus: PendingLead financial advisor to Centessa Pharmaceuticals on its acquisition by Eli Lilly
Announced: March 25, 2026Value: $6.7 billionStatus: PendingLead financial advisor to Terns Pharmaceuticals on its sale to Merck
Announced: January 6, 2026Value: $6.4 billionStatus: PendingFinancial advisor to OneStream on its acquisition by Hg
Announced: January 22, 2026Value: $5.15 billionStatus: PendingExclusive financial advisor to Brex on its sale to Capital One
Announced: May 7, 2026Value: $4.1 billionStatus: PendingLead financial advisor to Angelini Pharma on its acquisition of Catalyst Pharmaceuticals
Announced: May 18, 2026Value: Up to $3.875 billionStatus: ClosedFinancial advisor to Anglo American on the sale of its steelmaking coal business to Dhilmar
Announced: May 18, 2026Value: Up to $3.875 billionStatus: PendingFinancial advisor to Anglo American on the sale of its steelmaking coal business to Dhilmar
Announced: February 18, 2026Value: $3.1 billionStatus: PendingFinancial advisor to the special committee for Mister Car Wash
Announced: March 20, 2026Value: Up to $3 billionStatus: PendingExclusive financial advisor to Synnovation on its sale of Pikavation to Novartis
Announced: March 6, 2026Value: $2.5 billionStatus: PendingExclusive financial advisor to Day One on its sale to Servier
Announced: January 22, 2026Value: $2.25 billionStatus: PendingExclusive financial advisor to Clorox on its acquisition of GOJO Industries
Announced: January 5, 2026Value: $1.6 billionStatus: PendingFinancial advisor to Jacobs on its acquisition of the remaining shares of PA Consulting
Announced: April 22, 2026Value: $1.5 billionStatus: ClosedExclusive financial advisor to Vertical Bridge on its strategic equity investment from KKR
Announced: April 20, 2026Value: $1.4 billionStatus: PendingExclusive financial advisor to Honeywell on the sale of its Productivity Solutions and Services business to Brady Corporation
Announced: February 12, 2026Value: $1.3 billionStatus: PendingExclusive financial advisor to Deutsche Börse on its acquisition of the remaining stake in ISS STOXX
Announced: May 1, 2026Value: Up to $1.1 billionStatus: PendingFinancial advisor to Esperion Therapeutics on its acquisition by ARCHIMED
Announced: June 8, 2026Value: $1.0 billionStatus: PendingExclusive financial advisor to Firefly Bio on its sale to J&J
Announced: April 30, 2026Value: $1 billionStatus: PendingLead financial advisor to Daily Mail and General Trust on the sale of Trepp, its real estate data and analytics business, to Fitch Group
Announced: January 16, 2026Value: $1 billionStatus: PendingFinancial advisor to SEEQC on its agreement to combine with Allegro Merger Corp, supported by a $65 million PIPE financing
Announced: February 25, 2026Value: $950 millionStatus: PendingLead financial advisor to 35Pharma on its sale to GSK
Announced: March 19, 2026Value: Up to $785 millionStatus: PendingExclusive financial advisor to Corium on its sale of AZSTARYS to Collegium Pharmaceutical
Announced: January 7, 2026Value: $550 millionStatus: PendingExclusive financial advisor to D-Wave on its acquisition of Quantum Circuits
Announced: February 4, 2026Value: $400 millionStatus: PendingExclusive financial advisor to Bachan's on its sale to The Marzetti Company
Announced: January 28, 2026Value: Up to $400 millionStatus: PendingExclusive financial advisor to Surf Bio on its sale to Halozyme Therapeutics
Announced: May 19, 2026Value: Up to $130 millionStatus: ClosedExclusive financial advisor to Hansa Biopharma on its licensing agreement with SERB Pharmaceuticals
Announced: June 9, 2026Value: $10.6bnStatus: PendingCenterview partners as exclusive financial advisor to Nuvalent
Announced: June 8, 2026Value: $460mmStatus: PendingCenterview as Financial Advisor to Standard BioTools on Merger with Treeline Biosciences
Announced: June 2, 2026Value: £337mmStatus: PendingCenterview as exclusive financial advisor to Wiley on their acquisition of Emerald from Cambridge Information Group
Announced: June 1, 2026Value: Up to $2.65bnStatus: PendingExclusive financial advisor to Edgewise on its sale of Sevasemten to Servier
Announced: June 1, 2026Value: $1.5bnStatus: PendingFinancial Advisor to Motorola Solutions on their acquisition of D-Fend Solutions
Announced: May 28, 2026Status: PendingExclusive Financial Advisor to Tractor Supply Company on their acquisition of VIP Petcare
Announced: May 26, 2026Value: Up to $1.5bnStatus: PendingFinancial advisor to Curevo on its sale to Eli Lilly
Announced: May 21, 2026Value: $69bnStatus: PendingCenterview served as lead financial advisor to Equity Residential in their merger with AvalonBay Communities
Announced: May 6, 2026Status: PendingExclusive financial advisor to Perfuse Therapeutics on its sale to Bayer AG
Announced: April 30, 2026Status: ClosedExclusive financial advisor to Estée Lauder on its minority investment in 111SKIN
Announced: April 29, 2026Value: Up to $900mmStatus: PendingFinancial Advisor on its sale to Teva
Announced: April 29, 2026Value: $1.9bnStatus: PendingFinancial Advisor to KalVista on its sale to Chiesi
Announced: April 27, 2026Status: PendingExclusive financial advisor to Bernhard on its acquisition of Cleco Group in conjunction with Stonepeak Partners
Announced: April 23, 2026Status: PendingExclusive financial advisor to Honeywell on the sale of its Warehouse and Workflow Solutions business to American Industrial Partners
Announced: April 17, 2026Value: Up to $1.15bnStatus: PendingCenterview as exclusive financial advisor to Neurona on its sale to UCB
Announced: April 13, 2026Status: PendingFinancial advisor to Thoma Bravo and HCSS on HCSS’ combination with Nemetschek Group’s Build & Construct segment
Announced: April 7, 2026Value: Up to $5.0bnStatus: PendingFinancial advisor to Gilead on its acquisition of Tubulis
Announced: April 6, 2026Value: $2.9bnStatus: PendingLead financial advisor to Soleno on its sale to Neurocrine
Announced: April 2, 2026Status: PendingCenterview as sole financial advisor to TMRW on their merger and Series E
Announced: April 1, 2026Status: PendingCenterview as financial advisor to Aptiv in its separation of Versigent
Announced: March 29, 2026Status: ClosedFinancial advisor to iBase-t on its strategic growth investment from TA Associates
Announced: March 27, 2026Value: Up to $1.225bnStatus: PendingExclusive financial advisor to Transcend on its sale to Otsuka
Announced: March 23, 2026Value: Up to $2.175bnStatus: PendingExclusive financial advisor to Gilead on its acquisition of Ouro Medicines
Announced: March 23, 2026Status: PendingExclusive financial advisor to Huel on its sale to Danone
Announced: February 23, 2026Status: PendingExclusive financial advisor to 1touch on its sale to Everpure
Announced: February 9, 2026Status: PendingLead financial advisor to Linden on their agreement to sell a 50% stake in Regenity Biosciences to Cinven
Announced: January 12, 2026Status: PendingFinancial advisor to Radius on B FLEXION's acquisition of the remaining interest in Radius
Announced: January 7, 2026Status: ClosedLead financial advisor to Blackstone on its acquisition of the remaining stake in AIR Control Concepts